Shaddari leverages data with their artificial intelligence based APIs to build decision support tools in healthcare.
Shaddari Therapeutics has raised $269K in total funding. The most recent round was Grant. The last funding was announced in July 2022.
Shaddari Therapeutics's investors include Next AI, NEXT Canada, Innovative Solutions Canada.
Shaddari Therapeutics is headquartered in Montreal, Canada.
Shaddari leverages data with their artificial intelligence based APIs to build decision support tools in healthcare.
Shaddari Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Shaddari Therapeutics — Funding & Investors." VCBacked, July 11, 2022, https://www.vcbacked.co/company/shaddari-therapeutics. Accessed August 14, 2026.
VCBacked. (2022). Shaddari Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/shaddari-therapeutics
{{cite web |title=Shaddari Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/shaddari-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated